{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:49:12Z","timestamp":1782449352595,"version":"3.54.5"},"reference-count":78,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Venous thromboembolism (VTE) remains a clinically relevant complication of radical prostatectomy despite advances in surgical techniques and perioperative care. Current thromboprophylaxis strategies are largely based on fixed-duration approaches and static risk models focused on the early postoperative period. However, accumulating evidence suggests that postoperative hypercoagulability is a dynamic and prolonged process that may extend beyond this timeframe. This review summarizes the pathophysiological mechanisms and temporal dynamics of postoperative hypercoagulability after radical prostatectomy, with particular emphasis on biomarker-based evidence, including thrombin generation and von Willebrand factor. Clinical and laboratory findings suggest that haemostatic activation may persist after hospital discharge, supporting the concept of a biologically relevant post-discharge period during which insufficiently captured thrombotic risk may remain despite apparent clinical recovery. Current risk assessment models do not account for the time-dependent nature of postoperative haemostatic changes and do not incorporate biomarker data. This discrepancy highlights a gap between guideline-based thromboprophylaxis strategies and the underlying biological processes. To address this, we propose a conceptual framework in which postoperative thromboprophylaxis is considered in relation to the temporal evolution of hypercoagulability. This framework is hypothesis-generating and may help inform future studies aimed at identifying patients who could benefit from extended prophylaxis while avoiding unnecessary anticoagulation in those with more rapid haemostatic recovery. Further prospective studies are required to validate biomarker-guided strategies and to define clinically actionable thresholds for individualized thromboprophylaxis in prostate cancer patients undergoing radical prostatectomy.<\/jats:p>","DOI":"10.3390\/jcm15124743","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T13:04:04Z","timestamp":1781874244000},"page":"4743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Persistent Hypercoagulability After Radical Prostatectomy: Biomarker Dynamics and Implications for Individualized Thromboprophylaxis"],"prefix":"10.3390","volume":"15","author":[{"given":"Matyas","family":"Benyo","sequence":"first","affiliation":[{"name":"FertiMed LP Outpatient Center, 4027 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Al-Muhanna","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of General Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Molnar","sequence":"additional","affiliation":[{"name":"FertiMed LP Outpatient Center, 4027 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7481-6630","authenticated-orcid":false,"given":"Janos","family":"Docs","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of General Medicine, University of Debrecen, 4032 Debrecen, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Takacs","sequence":"additional","affiliation":[{"name":"Centre of Assisted Reproduction, Department of Obstetrics and Gynaecology, Semmelweis University, 1097 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan","family":"Harsfalvi","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Radiation Biology, Faculty of General Medicine, Semmelweis University, 1094 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"180119","DOI":"10.1183\/16000617.0119-2018","article-title":"Cancer-associated thrombosis: The when, how and why","volume":"28","author":"Fernandes","year":"2019","journal-title":"Eur. Respir. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jpedsurg.2021.01.047","article-title":"Risk for deep venous thrombosis in pediatric cancer patients undergoing surgery","volume":"56","author":"Spiegl","year":"2021","journal-title":"J. Pediatr. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eururo.2025.07.023","article-title":"Re: EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer","volume":"89","author":"Santiago","year":"2026","journal-title":"Eur. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000353918","article-title":"Present practice of thrombosis prophylaxis of radical prostatectomy in a European country: A Hungarian multicenter study","volume":"92","author":"Benyo","year":"2014","journal-title":"Urol. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00345-019-02705-x","article-title":"Perioperative venous thromboembolism prophylaxis in prostate cancer surgery","volume":"38","author":"Klaassen","year":"2020","journal-title":"World J. Urol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/EJA.0000000000002012","article-title":"European guidelines on peri-operative venous thromboembolism prophylaxis: First update.: Chapter 12: Urology","volume":"41","author":"Tikkinen","year":"2024","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.juro.2008.12.027","article-title":"AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery","volume":"181","author":"Forrest","year":"2009","journal-title":"J. Urol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"E227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/SLA.0b013e31821b98da","article-title":"Post-discharge venous thromboembolism after cancer surgery: Extending the case for extended prophylaxis","volume":"254","author":"Merkow","year":"2011","journal-title":"Ann. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Benyo, M., Flasko, T., Molnar, Z., Kerenyi, A., Batta, Z., Jozsa, T., and Harsfalvi, J. (2012). Follow-up of thrombin generation after prostate cancer surgery: Global test for increased hypercoagulability. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051299"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.urolonc.2019.10.007","article-title":"Long-lasting prothrombotic state implied by changes of plasma von Willebrand factor parameters after radical prostatectomy for prostate malignancy","volume":"38","author":"Harsfalvi","year":"2020","journal-title":"Urol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e038045","DOI":"10.1136\/bmjopen-2020-038045","article-title":"Pronounced haemodynamic changes during and after robotic-assisted laparoscopic prostatectomy: A prospective observational study","volume":"10","author":"Pawlik","year":"2020","journal-title":"BMJ Open"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12032-019-1331-8","article-title":"Venous thromboprophylaxis in urological cancer surgery","volume":"37","author":"Michalski","year":"2019","journal-title":"Med. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nasser, N.J., Fox, J., and Agbarya, A. (2020). Potential Mechanisms of Cancer-Related Hypercoagulability. Cancers, 12.","DOI":"10.3390\/cancers12030566"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0049-3848(13)70024-0","article-title":"Mechanisms of thrombosis in cancer","volume":"131","author":"Falanga","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.thromres.2010.09.002","article-title":"Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay","volume":"126","author":"Debaugnies","year":"2010","journal-title":"Thromb. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/jth.14976","article-title":"Von Willebrand factor and cancer; metastasis and coagulopathies","volume":"18","author":"Patmore","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Reardon, B., Pasalic, L., and Favaloro, E.J. (2021). The Intriguing Relationships of von Willebrand Factor, ADAMTS13 and Cardiac Disease. J. Cardiovasc. Dev. Dis., 8.","DOI":"10.3390\/jcdd8090115"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Reikeras, O., and Borgen, P. (2014). Activation of markers of inflammation, coagulation and fibrinolysis in musculoskeletal trauma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107881"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archsurg.141.11.1132","article-title":"Cell response to surgery","volume":"141","author":"Redmond","year":"2006","journal-title":"Arch. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bja\/85.1.109","article-title":"The stress response to trauma and surgery","volume":"85","author":"Desborough","year":"2000","journal-title":"Br. J. Anaesth."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1055\/s-0041-1722971","article-title":"Altered Fibrinolysis during and after Surgery","volume":"47","author":"Colomina","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00464-022-09361-0","article-title":"Risk factors associated with venous thromboembolism in laparoscopic surgery in non-obese patients with benign disease","volume":"37","author":"Kano","year":"2023","journal-title":"Surg. Endosc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2020003135","article-title":"Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism","volume":"5","author":"Edvardsen","year":"2021","journal-title":"Blood Adv."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Favaloro, E.J., and Gosselin, R.C. (2023). Hemostasis and Thrombosis: An Overview Focusing on Associated Laboratory Testing to Diagnose and Help Manage Related Disorders. Hemostasis and Thrombosis: Methods and Protocols, Springer.","DOI":"10.1007\/978-1-0716-3175-1_1"},{"key":"ref_30","first-page":"17263","article-title":"Hemostasis assessment in patients suspected of venous thrombosis and pulmonary embolism in emergency setting: Challenges for clinicians","volume":"136","author":"Lippi","year":"2026","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jth.14343","article-title":"High levels of coagulation factors and venous thrombosis risk: Strongest association for factor VIII and von Willebrand factor","volume":"17","author":"Rietveld","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1538-7836.2005.01369.x","article-title":"von Willebrand factor: Two sides of a coin","volume":"3","author":"Sadler","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_33","first-page":"141","article-title":"Inflammation, von Willebrand factor, and ADAMTS13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0049-3848(88)90364-7","article-title":"Changes in blood coagulation and fibrinolysis in patients on different treatment regimens for prostatic cancer. Predictors for cardiovascular complications?","volume":"49","author":"Blomback","year":"1988","journal-title":"Thromb. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0304-3835(88)90087-0","article-title":"Immunoquantitation of factor VIII-related antigen (von Willebrand factor antigen) in prostate cancer","volume":"40","author":"Ablin","year":"1988","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/pros.21319","article-title":"Endothelial progenitor cells and circulating endothelial cells in early prostate cancer: A comparison with plasma vascular markers","volume":"71","author":"Blann","year":"2011","journal-title":"Prostate"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/jth.13205","article-title":"ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer","volume":"14","author":"Pepin","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/hae.12185","article-title":"Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals","volume":"19","author":"Kahlon","year":"2013","journal-title":"Haemophilia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1076029612470489","article-title":"Prethrombotic state and cardiac events in patients with coronary heart disease during noncardiac surgery","volume":"20","author":"Zheng","year":"2014","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/bjs.10107","article-title":"Balance between von Willebrand factor and ADAMTS13 following major partial hepatectomy","volume":"103","author":"Groeneveld","year":"2016","journal-title":"Br. J. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","article-title":"A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS project","volume":"243","author":"Agnelli","year":"2006","journal-title":"Ann. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/bju.13496","article-title":"Guideline of guidelines: Thromboprophylaxis for urological surgery","volume":"118","author":"Violette","year":"2016","journal-title":"BJU Int."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1177\/03946320110240S302","article-title":"Perioperative period: Immunological modifications","volume":"24","author":"Cardinale","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_44","first-page":"2011","article-title":"Biomarkers for prediction of venous thromboembolism in cancer","volume":"122","author":"Pabinger","year":"2013","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"307.e15","DOI":"10.1016\/j.urolonc.2018.03.003","article-title":"Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery","volume":"36","author":"Shi","year":"2018","journal-title":"Urol. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Yang, H., He, C., Bi, Y., Zhu, X., Deng, D., Ran, T., and Ji, X. (2022). Synergistic effect of VEGF and SDF-1alpha in endothelial progenitor cells and vascular smooth muscle cells. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.914347"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5620314","DOI":"10.1155\/2017\/5620314","article-title":"The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy","volume":"2017","author":"Gragnano","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.13898","article-title":"ADAMTS-13 and von Willebrand factor: A dynamic duo","volume":"16","author":"South","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.urolonc.2017.12.010","article-title":"The role of extended venous thromboembolism prophylaxis following urologic pelvic surgery","volume":"36","author":"Sagalovich","year":"2018","journal-title":"Urol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0043-1775856","article-title":"Thrombin Generation Markers as Predictors of Cancer-Associated Venous Thromboembolism: A Systematic Review","volume":"50","author":"Gyldenholm","year":"2024","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/a-2753-9825","article-title":"Thrombin Generation Assays: Possibilities and Limitations","volume":"46","author":"Pezeshkpoor","year":"2026","journal-title":"Hamostaseologie"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1309\/AJCP6AY4HTRAAJFQ","article-title":"Optimization of plasma fluorogenic thrombin-generation assays","volume":"132","author":"Chandler","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"109384","DOI":"10.1016\/j.thromres.2025.109384","article-title":"Thrombin generation assay in venous thromboembolism: A scoping review","volume":"252","author":"Souza","year":"2025","journal-title":"Thromb. Res."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Reddel, C.J., Tan, C.W., and Chen, V.M. (2019). Thrombin Generation and Cancer: Contributors and Consequences. Cancers, 11.","DOI":"10.3390\/cancers11010100"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1538-7836.2009.03561.x","article-title":"Peak thrombin generation and subsequent venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE) study","volume":"7","author":"Lutsey","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1111\/j.1538-7836.2011.04488.x","article-title":"Differential Contributions of Monocyte- and Platelet-derived Microparticles towards Thrombin Generation and Fibrin Formation and Stability","volume":"9","author":"Aleman","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1160\/TH06-09-0523","article-title":"Plasma tissue factor antigen in localized prostate cancer: Distribution, clinical significance and correlation with haemostatic activation markers","volume":"97","author":"Langer","year":"2007","journal-title":"Thromb. Haemost."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s007760200077","article-title":"Changes in LPIA D-dimer levels after total hip or knee arthroplasty relevant to deep-vein thrombosis diagnosed by bilateral ascending venography","volume":"7","author":"Shiota","year":"2002","journal-title":"J. Orthop. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"b4583","DOI":"10.1136\/bmj.b4583","article-title":"Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: Prospective cohort study","volume":"339","author":"Sweetland","year":"2009","journal-title":"BMJ"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jvssci.2021.08.002","article-title":"Role of von Willebrand factor in venous thromboembolic disease","volume":"3","author":"Michels","year":"2022","journal-title":"JVS Vasc. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/bjs\/znad035","article-title":"Timing of symptomatic venous thromboembolism after surgery: Meta-analysis","volume":"110","author":"Singh","year":"2023","journal-title":"Br. J. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5551\/jat.65177","article-title":"Inflammatory Biomarkers as Predictors of Symptomatic Venous Thromboembolism in Hospitalized Patients with AECOPD: A Multicenter Cohort Study","volume":"32","author":"Zeng","year":"2025","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.jtha.2023.04.038","article-title":"Plasma levels of P-selectin and future risk of incident venous thromboembolism","volume":"21","author":"Swamy","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2020.06.012","article-title":"Mechanisms and biomarkers of cancer-associated thrombosis","volume":"225","author":"Kim","year":"2020","journal-title":"Transl. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3892\/etm.2020.9574","article-title":"Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution","volume":"21","author":"Cheng","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1160\/TH05-06-0426","article-title":"D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis. A pilot study","volume":"94","author":"Rectenwald","year":"2005","journal-title":"Thromb. Haemost."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41598-025-85941-z","article-title":"Caprini score combined with thrombotic molecular markers for predicting DVT in patients with traumatic fractures","volume":"15","author":"Wu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4081\/aiua.2022.1.37","article-title":"Minimally invasive simple prostatectomy: Robotic-assisted versus laparoscopy. A comparative study","volume":"94","author":"Amenta","year":"2022","journal-title":"Arch. Ital. Urol. Androl."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Spirito, L., Sciorio, C., Romano, L., Di Girolamo, A., Ruffo, A., Romeo, G., Crocetto, F., Napolitano, L., Stizzo, M., and Bottone, F. (2025). Impact of Nerve-Sparing Techniques on Prostate-Specific Antigen Persistence Following Robot-Assisted Radical Prostatectomy: A Multivariable Analysis of Clinical and Pathological Predictors. Diagnostics, 15.","DOI":"10.3390\/diagnostics15080987"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Wani, M., Al-Mitwalli, A., Mukherjee, S., Nabi, G., Somani, B.K., Abbaraju, J., and Madaan, S. (2023). Venous thromboembolism (VTE) in post-prostatectomy patients: Systematic review and meta-analysis. J. Clin. Med., 12.","DOI":"10.20944\/preprints202305.1469.v1"},{"key":"ref_73","first-page":"270","article-title":"Epidemiology of and Risk Factors in Postoperative Complications from Robotically Assisted Laparoscopic Radical Prostatectomy in Contemporary National Surgical Quality Improvement Program Data","volume":"38","author":"Homer","year":"2024","journal-title":"J. Endourol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2007.05.028","article-title":"Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy","volume":"53","author":"Secin","year":"2008","journal-title":"Eur. Urol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"718","DOI":"10.56434\/j.arch.esp.urol.20247707.100","article-title":"Impact of Immunohistochemical Biomarkers on Predicting the Risk of Biochemical Recurrence for Patients that Underwent Radical Prostatectomy: A Literature Review","volume":"77","author":"Borz","year":"2024","journal-title":"Arch. Esp. Urol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"103077","DOI":"10.1016\/j.fjurol.2026.103077","article-title":"Hemorrhagic and thrombotic complications following robotic-assisted prostatectomy (RALP) with risk-adapted antithrombotic prophylaxis: A retrospective study","volume":"36","author":"Rondot","year":"2026","journal-title":"Fr. J. Urol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1245\/s10434-022-11574-5","article-title":"Construction and verification of risk predicting models to evaluate the possibility of venous thromboembolism after robot-assisted radical prostatectomy","volume":"29","author":"Cheng","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Manivasagam, S.S., Aminsharifi, A., and Raman, J.D. (2026). Incidence and predictors of venous thromboembolism following major urologic cancer surgery: Toward risk-stratified, personalized prophylaxis strategies. J. Pers. Med., 16.","DOI":"10.3390\/jpm16020082"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:26:08Z","timestamp":1782447968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":78,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124743"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124743","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}